Drug intelligence / Profile preview

Rheumate

Development stage
Unknown
Lead developer
Primus Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Rheumate is a prescription medical food developed by Primus Pharmaceuticals for the clinical dietary management of the metabolic effects and side effects associated with methotrexate (MTX) therapy in patients with rheumatoid arthritis. Methotrexate acts as a folate antagonist by inhibiting the enzyme dihydrofolate reductase, which can lead to folate deficiency and associated toxicities such as gastrointestinal distress, liver dysfunction, and cognitive impairment (often referred to as "MTX fog"). Rheumate contains a specific combination of L-methylfolate (the active form of folate), cobalamin (Vitamin B12), and caffeine. L-methylfolate bypasses the metabolic block created by MTX to support cellular processes, while Vitamin B12 and caffeine are included to help mitigate fatigue and cognitive side effects. It is intended for use under medical supervision.

Brand names
Rheumate
02

Targets

MTR (Methionine synthase)ADORA2A (Adenosine A₂A Receptor)ADORA1 (Adenosine receptor A1 subtype)

Beyond the preview

Go deeper on Rheumate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rheumate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call